Intranasal corticosteroid

This page covers all Intranasal corticosteroid drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Glucocorticoid receptor.

Targets

Glucocorticoid receptor

Marketed (9)

• Ciclesonide nasal · McGill University Health Centre/Research Institute of the McGill University Health Centre · Allergy/Immunology
  Ciclesonide is an inhaled corticosteroid that reduces inflammation in the nasal airways by binding to glucocorticoid receptors and suppressing inflammatory mediator production.
• Mometasone furoate - intranasal application · Association Asthma, Bulgaria · Respiratory / Allergy / Immunology
  Mometasone furoate is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune cell activity and inflammatory mediator release.
• ciclesonide nasal aerosol · Sumitomo Pharma America, Inc. · Allergy/Immunology
  Ciclesonide is an inhaled corticosteroid that reduces inflammation in the nasal airways by binding to glucocorticoid receptors and suppressing inflammatory mediator production.
• TAA-AQ, Nasacort® AQ · Sanofi · Immunology / Allergy
  Triamcinolone acetonide aqueous suspension is a corticosteroid that reduces inflammation and immune response in the nasal passages.
• Nasal Beclomethasone Dipropionate · Stefania La Grutta, MD · Immunology / Allergy
  Beclomethasone dipropionate is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune cell activity and inflammatory mediator release.
• Fluticasone Furoate Nasal Spray · GlaxoSmithKline · Allergy/Immunology
  Fluticasone furoate is a corticosteroid that binds to glucocorticoid receptors in nasal tissue to reduce inflammation and allergic responses.
• Nasal Fluticasone · Children's Hospital of Philadelphia · Allergy/Immunology
  Fluticasone is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune cell activity and inflammatory mediator release.
• MF nasal spray · GlaxoSmithKline · Allergy/Immunology
  MF nasal spray is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune responses and decreasing mucus production.
• Ciclesonide nasal spray + placebo Azelastine · AstraZeneca · Allergy/Immunology
  Ciclesonide is an intranasal corticosteroid that reduces airway inflammation and mucus production to relieve nasal allergy symptoms.

Phase 3 pipeline (7)

• Intranasal Budesonide Spray · Second Xiangya Hospital of Central South University · Immunology / Allergy / Respiratory
  Budesonide is a corticosteroid that reduces inflammation in the nasal airways by suppressing immune cell activation and inflammatory mediator release.
• Beclomethasone dipropionate nasal spray · Organon and Co · Immunology / Respiratory
  Beclomethasone dipropionate is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune cell activity and inflammatory mediator release.
• Mometasone furoate nasal spray hormone · Beijing Tongren Hospital · Allergy/Immunology
  Mometasone furoate is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune and inflammatory responses.
• Nasonex Nasal Spray · National University of Malaysia · Allergy/Immunology
  Nasonex (mometasone furoate) is a intranasal corticosteroid that reduces inflammation in the nasal passages by binding to glucocorticoid receptors.
• BDP Nasal Aerosol · Teva Branded Pharmaceutical Products R&D, Inc. · Respiratory / Allergy
  BDP (beclomethasone dipropionate) is a corticosteroid that reduces inflammation in the nasal airways by suppressing immune responses and decreasing inflammatory mediator release.
• Mometasone furoate as a nasal spray · Zheng Liu ENT · Otolaryngology / Allergy
  Mometasone furoate is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune and inflammatory responses.
• Mometasone furoate NS · Glenmark Specialty S.A. · Immunology / Allergy / Rhinology
  Mometasone furoate is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune responses and decreasing inflammatory mediator release.